Profound sustained hypotension following renal denervation: a dramatic success?
- PMID: 26352181
- PMCID: PMC4559132
- DOI: 10.5935/abc.20150100
Profound sustained hypotension following renal denervation: a dramatic success?
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures

References
-
- Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57(6):1076–1080. - PubMed
-
- Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J. 2013;34(28):2159–2219. - PubMed
-
- DiBona GF. The sympathetic nervous system and hypertension: recent developments. Hypertension. 2004;43(2):147–150. - PubMed
-
- Krum H, Barman N, Schlaich M, Sobotka P, Esler M, Mahfoud F, et al. Symplicity HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911–917. - PubMed
-
- Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903–1909. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical